Federal Register of Legislation - Australian Government

Primary content

PB 53 of 2022 Determinations/Health as made
This instrument amends the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020) to increase fees as specified in the Seventh Community Pharmacy Agreement.
Administered by: Health
Registered 03 Jun 2022
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 53 of 2022

 

Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Amendment Determination 2022

National Health Act 1953

 

The Pharmaceutical Benefits Remuneration Tribunal makes this Determination under paragraph 98B(1)(a) of the National Health Act 1953.

 

Dated                 1 June 2022

 

 

 

 

 

ABBEYGAIL BEAUMONT
Chairperson
for and on behalf of the
Pharmaceutical Benefits Remuneration Tribunal

 


Contents

1 ........  Name............................................................................................................................... 1

2 ........  Commencement............................................................................................................... 1

3 ........  Authority......................................................................................................................... 1

4.........   Schedules....................................................................................................................... 1

Schedule 1—Amendments                                                                                            2

Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 2

6              Definitions……………………………………………….…………………………...2

12(1)       Ready‑prepared pharmaceutical benefits—administration, handling and infrastructure fee……………………………………………………………………...2

20            Extemporaneously‑prepared pharmaceutical benefits—administration, handling and infrastructure fee……………………………………………………………………...2

 


1  Name

(1)   This instrument is the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Amendment Determination 2022.

(2)   This instrument may also be cited as PB 53 of 2022.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 July 2022

1 July 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under paragraph 98B(1)(a) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020

1          Part 1, Section 6 Definitions

Omit:

“dangerous drug fee means an amount of $4.82.

extemporaneously-prepared dispensing fee means an amount of $9.82.

ready-prepared dispensing fee means an amount of $7.78.”

 

Substitute:

dangerous drug fee means an amount of $4.84.

extemporaneously-prepared dispensing fee means an amount of $9.86.

ready-prepared dispensing fee means an amount of $7.82.”

2          Part 2, Section 12(1)(a) (table)

Repeal the table at paragraph 12(1)(a), insert:

 

AHI Tier

Price to pharmacists for maximum quantity

Administration, handling and infrastructure fee for maximum quantity

1

< $100

$4.32

2

≥ $100, ≤ $2 000

Tier 1 AHI Fee + 5% of the amount by which the price to pharmacists for maximum quantity exceeds $100

3

> $2 000

$95.00 + Tier 1 AHI Fee

3          Part 3, Section 20 (table)

Repeal the table at section 20, insert:

 

AHI Tier

Price to pharmacists for maximum quantity

Administration, handling and infrastructure fee

1

< $100

$4.32

2

≥ $100, ≤ $2 000

Tier 1 AHI Fee + 5% of the amount by which the price to pharmacists for maximum quantity exceeds $100

3

> $2 000

$95.00 + Tier 1 AHI Fee